AstraZeneca says advanced trial of breast-cancer drug Capivasertib meets primary endpoints
AstraZeneca PLC said Wednesday that Capivasertib plus Faslodex significantly improved progression-free survival when compared with…
Read MoreAstraZeneca PLC said Wednesday that Capivasertib plus Faslodex significantly improved progression-free survival when compared with…
Read MoreU.S. Treasury Secretary Janet Yellen on Thursday said that central banks must continue the task…
Read MoreCopyright 2022 MarketWatch, Inc. All rights reserved. By using this site, you agree…
Read MoreWhen looking for offshore drilling employment, and in fact any job that requires a written…
Read More